Long-Term Follow-Up of Recipient of Gene Transfer Research

RecruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

December 9, 2011

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Retroviridae InfectionsCancer
Interventions
OTHER

Blood Tests

If participant received retroviral gene therapy, blood test performed to check for a type of infection called the replication-competent retrovirus (RCR). Blood (up to 4 tablespoons each time) drawn every 3 months for first year after gene transfer therapy and once a year after that.

BEHAVIORAL

Questionnaires

"Once a year during Years 1-5, questionnaire completions that asks about medical history (general health, the status of any medical conditions, and any illnesses or hospitalizations that may have occurred). It should take about 15-30 minutes to complete.~Once a year during Years 6-15, completion of mailed questionnaire. Participant will be asked about medical history (including if participant has had any children since the infusion) and whether there have been any changes in contact information. The questionnaires should take about 15-30 minutes each time."

Trial Locations (1)

77030

RECRUITING

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Alaunos Therapeutics

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER